HepFREEPak

Protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol

Bibliographic Data

ID15356935
AuthorsAmbreen Arif (0009-0001-3442-3955, Dow University of Health Sciences, corresponding author), Aliya Hasnain (Aga Khan University), Auj Chaudhry, Muhammad Asim (0000-0002-0905-0026, Dow University of Health Sciences), Muhammad Nabeel Shafqat (0000-0002-4725-8397), Altaf Awan (0000-0002-0150-074X, Dow University of Health Sciences), Abeer Altaf, Noore Saba (0000-0003-2208-3882, Aga Khan University), Noor Saba, Polychronis Kemos (Queen Mary University of London), M Azim Ansari (0000-0003-2790-8353, University of Oxford), Eleanor Barnes (0000-0002-0860-0831, Oxford University Hospitals NHS Trust), C Metcalfe (0000-0001-8318-8907, University of Bristol), Peter Vickerman (0000-0002-8291-5890, University of Bristol), Huma Qureshi (0000-0001-7120-4893, Dow University of Health Sciences), Saeed Hamid (0000-0001-7218-6885, Aga Khan University), Asad Ali Choudhry, Saad Khalid Niaz (0000-0001-5233-9258, Dow University of Health Sciences), Graham R Foster (0000-0002-3704-386X, Queen Mary University of London), Naheed Choudhry (0000-0002-2163-9423, Queen Mary University of London)
Year2023
Volume23
Issue1
Pages2529-2529
Publication date2023-12-18
Open AccessYes
TypeARTICLE
VenueBMC Public Health (JOURNAL)
Journal identifiersISSN: 1471-2458 • E-ISSN: 1471-2458
PublisherBioMed Central (PUBLISHER • GB)
DOI10.1186/s12889-023-17290-3
PMID38110885
OpenAlexW4389894528
LanguageEN
References cited15

Tools

Open DOIOpen Access